Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.5 USD | -4.49% |
|
-9.48% | +45.05% |
05-14 | Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M | MT |
2023 | NovaBay to Commercialize BioStem's Amniotic Tissue Allograft | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
122B | ||||||
114B | ||||||
25.71B | - | |||||
19.02B | - | |||||
15.83B |
- Stock Market
- Equities
- Stock
- BSEM Stock
- Charts BioStem Techn.
- Sector Chart